MyJournals Home  

RSS FeedsPTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy (Oncogene)

 
 

25 september 2017 18:33:06

 
PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy (Oncogene)
 




 
225 viewsCategory: Oncology
 
Exercise-dependent regulation of the tumour microenvironment (Nature Reviews Cancer)
Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others (Nature Clinical Practice Oncology)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Oncology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten